ALNYLAM PHARMACEUTICALS INC
ALNYNASDAQ$252.86▼ $2.48 (−0.98%)
LiveTrack ALNY
Get earnings, price moves & breaking news on Telegram
24h▼ 1.0%
7d▲ 0.5%
14d▲ 6.1%
30d▲ 6.7%
ytd▼ 36.4%
1y▼ 43.5%
🏦Market Cap
$33.83B
Mid Cap
📈Revenue Growth (YoY)
+65.2%
High Growth
📊Gross Margin
79.7%
High
💵FCF Margin
11.3%
Healthy
⚖️P/S Ratio
7.1x
Fair
Otter Score
56
Weak
Earnings
Q3 · 2026Reported 2026-07-30Earnings Per Share
Actual
1.21
Expected
1.63
miss
−25.80%
YoY +337.30%
Revenue
Actual
$1.29B
Expected
$1.32B
miss
−2.40%
YoY +66.90%
Consensus estimates
Recent quarters
Q3 2026
1.21
miss
Q2 2026
1.51
beat
Q1 2026
0.82
miss
Q4 2025
1.84
beat